World's first quantum dot medical test reagent developed successfully

Release time: 2017-01-14


Quantum technology has been researched in many fields around the world, and there are scientific research institutions in China tried to apply quantum technology to the medical field as early as ten years ago, but up to now, there are still no related products on the market. Five years ago, Shenzhen Da Ai Medical Technology Co., Ltd. located in Xixiang Street, Baoan District, noticed the broad prospects of quantum technology products in the field of medical applications, and began to form a team to develop related products。

 

新闻

 

It is understood that the principle of the product is the use of high efficiency fluorescent quantum dots, a new generation of biomarker materials to test reagents for full quantitative rapid detection and analysis. Quantum dots, also known as nanocrystals, are a type of nanomaterial. The size of quantum dots in three dimensions are below 100 nanometers, the internal movement of electrons in all directions are limited, the continuous energy band structure into a discrete energy level structure with molecular properties, and can emit fluorescence after excitation.

According to the product leader Zhang Jianguo, the company's R & D team has successfully developed calcitoninogen detection reagent using quantum technology is a product that can already be marketed, and there are 12 other related projects undergoing clinical validation experiments, which are expected to get the marketing license in 2-3 months, among which ultrasensitive calcitoninogen will be the only detection reagent in China that can be used in peripheral blood (fingertip blood) for related testing, especially suitable for It is especially suitable for testing children who have difficulties in blood collection.

Recommended news

Keep abreast of company news and industry news

National Development and Reform Commission issued the "Thirteenth Five-Year Plan" for the development of bio-industry

In January 2017, the Development and Reform Commission issued the "13th Five-Year Plan" for the development of the biological industry, which pointed out the direction of the key issues and

6xHis Labeled Protein Nickel Column Purification Method Protocol

1. Solution preparation: 1.1 Binding Buffer: 10mM PB, 500mM NaCl, 10mM imidazole, pH7.4. 1.2 Elution Buffer1: 10mM PB, 500mM NaCl, 50mM imidazole, pH 7.4.

Jingcheng CrystaroseC FF filler test report

1、Apparatus and consumables 1.1 Instrument: JC-1 automated protein purification system (Jingcheng) 1.2 Chromatographic column: XK16 (GE) 1.3 Jingcheng Biotechnology: CrystaroseC FF(5ml)

Metal chelate chromatography affinity packing comparable to imported products

CrystaroseC FF metal chelate chromatography affinity packing has super high rigidity, higher linear flow rate up to 700cm/h, and the back pressure is close to the imported similar products or even lower. Therefore, the packing life is longer.